Asensus Surgical (TransEnterix)

Asensus Surgical (TransEnterix) is an American medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company was founded in 2006 and is based in Morrisville, North Carolina.
Asensus Surgical (TransEnterix) stock price chart
-60%
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Asensus Surgical (TransEnterix) balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Asensus Surgical (TransEnterix) cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Asensus Surgical (TransEnterix) multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Asensus Surgical (TransEnterix) profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Asensus Surgical (TransEnterix) assets
Asensus Surgical (TransEnterix) cash flows

Asensus Surgical (TransEnterix) dividend policy

The company doesn't provide dividend

Asensus Surgical (TransEnterix) shares

TickerNameTypeNominal valueISINPrice
ASXC:USAsensus Surgical (TransEnterix)Common share-US04367G1031$0.2401
Asensus Surgical (TransEnterix) news
05.05.2022
Asensus Surgical's GAAP loss for the 3 months of 2022 was $19.128 million, up 10.3% from $17.34 million in the prior year. Revenue decreased 48.8% to $1.066 million from $2.083 million a year earlier.
01.03.2022
Asensus Surgical's GAAP loss for 2021 was $62.462 million, up 5.3% from $59.312 million the previous year. Revenue increased 2.6 times to $8.232 million from $3.175 million a year earlier.
04.11.2021
Asensus Surgical reported a GAAP loss of $46.581 million for 9M 2021, up 2.3% from $45.521 million in the previous year. Revenue increased 2.8 times to $5.756 billion from $2.068 billion a year earlier.
06.08.2021
Asensus Surgical's GAAP loss for six months of 2021 was $30.512 million, up 0.2% from $30.438 million in the prior year. Revenue increased 2.5 times to $3.185 million from $1.255 million a year earlier.
General information
Company nameAsensus Surgical (TransEnterix)
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address635 Davis Drive Suite 300 Morrisville, NC 27560 United States
Mailing address635 Davis Drive Suite 300 Morrisville, NC 27560 United States
Websiteir.transenterix.com
Information disclosurewww.sec.gov